Back to MOLNView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Chronic Phase Chronic Myeloid Leukemia
View Full LandscapeDrug Information
Target Indication
Chronic Phase Chronic Myeloid Leukemia
Clinical Trial
NCT01593254Last updated: 8/16/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
4D-150 IVT (3E10 vg/eye)Phase 3
Macular Neovascularization Secondary to Age-Related Macular Degeneration
MP0420Phase 3
COVID-19
4D-150 IVT (3x10^10 vg)Phase 3
Diabetic Macular Edema (DME)
MP0250 plus BOR+DEXPhase 2
Multiple Myeloma in Relapse
[212Pb]Pb-MP0712Phase 2
Large Cell Neuroendocrine Carcinoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts